The bond proceeds of $360 million will be used for construction, renovation and expansion projects at the system’s facilities.
The rating assignment was based on a number of factors, including Texas Health’s very good operating results and leading market share, according to Kevin Holloran, an S&P credit analyst.
The system’s outlook is stable, which reflects S&P’s expectation that Texas Health will continue its track record of solid operating income levels and also continue to prepare for population health management.
More articles on healthcare finance:
The $253M battle between 2 Illinois hospitals
Erlanger profit increases on higher patient volume
Mercy Health’s profit plummets 62% in 2014
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
